30
Participants
Start Date
July 31, 2011
Primary Completion Date
April 30, 2014
Study Completion Date
April 30, 2014
Heparin 2,400 IU /ml Cutaneous Spray
Randomization will be performed 2 - 14 days post fistula creation surgery following confirmation that the fistula is patent by physical examination. Patients that are randomized to this study arm, will be asked to administer the study medication twice daily. Patients will get adequate training before first administration.
Placebo Cutaneous Spray
Randomization will be performed 2 - 14 days post fistula creation surgery following confirmation that the fistula is patent by physical examination. Patients that are randomized to this study arm, will be asked to administer the study medication (placebo) twice daily. Patients will get adequate training before first administration.
Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie und Dialyse, Medizinische Universität Wien, Vienna
6. Medizinische Abteilung mit Nephrologie und Dialyse, Wilhelminenspital Wien, Vienna
Krankenhaus der Elisabethinen Linz, Linz
Lead Sponsor
Cyathus Exquirere Pharmaforschungsgmbh
INDUSTRY